Review of Natural Product Proteasome Inhibitors for Cancer Therapy, 2025 Literature

A 312 KB PDF review article summarizing clinical applications of proteasome inhibitors and natural products targeting the proteasome. The work, authored by Xiu Zhao and last updated in May 2026, compiles relevant clinical trials and literature published up to 2025 from sources like PubMed and ClinicalTrials.gov.

Use Cases

• Literature review on proteasome inhibitor development based on the described summary of clinical applications.
• Identifying candidate natural products for drug discovery based on the described focus on structure-activity relationships.
• Analyzing strategies to overcome drug resistance in cancer therapy based on the described discussion of rational combinations.

Strengths

• File size is precisely 312.0 KB, indicating a concise document.
• License is clearly defined as CC-BY-4.0, permitting reuse with attribution.
• Last update timestamp is provided (2026-05-04 05:30:30).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is a single 312 KB PDF file, representing a limited scope of information.

Provenance

Source

figshare

Collection Method

Literature review from PubMed, Web of Science, Google Scholar, and ClinicalTrials.gov.

Time Range

Literature published up to 2025.

Freshness

Last updated 2026-05-04 05:30:30; freshness should be verified.

Geography

null